Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,427.70
-21.00 (-1.45%)
Nov 21, 2025, 3:30 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 149.36 billion as of November 21, 2025. Its market cap has decreased by -23.30% in one year.
Market Cap
149.36B
Enterprise Value
146.06B
Revenue
11.25B
Ranking
n/a
PE Ratio
46.22
Stock Price
1,427.70
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 149.36B, an increase of 51.43%. That is a compound annual growth rate of 20.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 149.36B | -35.42% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.27T |
| Divi's Laboratories | 1.69T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.06T |
| Zydus Lifesciences | 930.06B |
| Mankind Pharma | 925.45B |
| Aurobindo Pharma | 700.39B |
| Fortis Healthcare | 695.32B |